Published in N Engl J Med on February 07, 2002
Diabetes Prevention Program Outcomes Study (DPPOS) | NCT00038727
Atkins Diet and Prostate Cancer Clinical Trial | NCT00932672
Weight Management in Nonalcoholic Steatohepatitis | NCT00266019
Evaluation of Group Lifestyle Balance DVD in Primary Care Practice (STEPUP) | NCT00480779
Age, Lifestyle, Muscle Mechanisms in Insulin Resistance | NCT00971594
Qingdao Diabetes Prevention Project (QDDPP) | NCT01053195
Prevention of Diabetes and Hypertension (PHIDIAS) | NCT00456963
Virtual Lifestyle Management: Prevention Through the UPMC Patient Portal | NCT00409786
The Effects of Metformin on Blood Vessel Structure and Function | NCT00105066
Rosiglitazone to Reverse Metabolic Defects in Diabetes | NCT00094796
Diabetes Prevention Program in Youth | NCT03042936
Progression From Impaired Fasting Glucose to Diabetes Mellitus Among Chinese | NCT03617757
Diabetes and Osteopathic Manipulative Medicine (OMM) | NCT03663322
Iron Reduction by Phlebotomy to Improve Diabetes Control | NCT03696797
Community Based DPP Program for Hispanic/Latino Females | NCT04052815
The Genomic Medicine at VA Study (GenoVA) | NCT04331535
GluCoach - Technology-enabled Lifestyle Intervention Study | NCT04905680
Optimal Metabolic Health Through Continuous Glucose Monitoring (CGM) | NCT04920058
Dietary Oxysterols and β-Cell Function Among African Americans | NCT05072587
Balance After Baby Intervention for Women With Recent Gestational Diabetes (BABI2) | NCT02744300
Physical Activity and Sedentary Behavior Change; Impact on Lifestyle | NCT02467881
Canadian Health Advanced By Nutrition and Graded Exercise (CHANGE) | NCT01616563
The Effects of Vitamin E and Vitamin C and Exercise | NCT01369043
Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care (2009) 26.77
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Health benefits of physical activity: the evidence. CMAJ (2006) 19.45
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care (2002) 11.65
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care (2008) 10.90
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart (2005) 9.79
Diagnosis and classification of diabetes mellitus. Diabetes Care (2011) 9.37
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03
The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 8.91
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med (2010) 8.77
The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) (2006) 8.25
Exercise and cardiovascular risk reduction: time to update the rationale for exercise? J Appl Physiol (1985) (2008) 8.17
Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75
Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care (2006) 7.09
Financial incentive-based approaches for weight loss: a randomized trial. JAMA (2008) 7.01
Diagnosis and classification of diabetes mellitus. Diabetes Care (2013) 6.83
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med (2005) 6.63
Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care (2011) 6.48
Prediabetes: a high-risk state for diabetes development. Lancet (2012) 6.42
Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care (2010) 6.10
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ (2010) 6.05
A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med (2011) 5.98
Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med (2004) 5.97
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med (2005) 5.76
Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res (2004) 5.74
The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 5.63
Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46
Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med (2008) 5.40
The metabolic syndrome. Endocr Rev (2008) 5.33
The role of exercise and PGC1alpha in inflammation and chronic disease. Nature (2008) 5.31
Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A (2009) 5.19
Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA (2012) 5.15
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care (2005) 5.10
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet (2011) 4.99
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet (2009) 4.96
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet (2016) 4.80
The burden of non communicable diseases in developing countries. Int J Equity Health (2005) 4.61
Gestational diabetes mellitus. J Clin Invest (2005) 4.60
Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes (2008) 4.57
Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care (2011) 4.38
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet (2012) 4.33
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab (2008) 4.29
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care (2003) 4.22
One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring) (2009) 4.08
A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults. Int J Behav Nutr Phys Act (2010) 4.05
Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) (2012) 4.04
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol (2006) 4.02
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care (2010) 3.98
Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med (2008) 3.79
The reality of type 2 diabetes prevention. Diabetes Care (2014) 3.74
National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health (2012) 3.72
Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. Am J Psychiatry (2013) 3.69
Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med (2013) 3.69
Interdisciplinarity and systems science to improve population health: a view from the NIH Office of Behavioral and Social Sciences Research. Am J Prev Med (2008) 3.69
Long-term drug treatment for obesity: a systematic and clinical review. JAMA (2014) 3.69
Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ (2009) 3.68
Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64
Diabetes in older adults: a consensus report. J Am Geriatr Soc (2012) 3.63
Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) (2011) 3.62
Diabetes in older adults. Diabetes Care (2012) 3.62
Improving the nutritional resource environment for healthy living through community-based participatory research. J Gen Intern Med (2003) 3.60
Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health (2011) 3.55
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology (2010) 3.55
Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest (2008) 3.51
Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr (2012) 3.48
A comprehensive review on metabolic syndrome. Cardiol Res Pract (2014) 3.47
Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial. BMJ (2008) 3.43
Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial. JAMA (2012) 3.40
The importance of place of residence: examining health in rural and nonrural areas. Am J Public Health (2004) 3.37
Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care (2003) 3.37
Multiple behavior changes in diet and activity: a randomized controlled trial using mobile technology. Arch Intern Med (2012) 3.35
Naturopathic medicine for the prevention of cardiovascular disease: a randomized clinical trial. CMAJ (2013) 3.25
Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes (2007) 3.23
Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect (2012) 3.17
Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract (2008) 3.16
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia (2007) 3.13
The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care (2012) 3.12
Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med (2015) 3.11
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (1997) 49.11
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 34.34
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care (1998) 18.69
The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care (1999) 16.79
The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. Diabetes Care (2000) 10.08
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes (1997) 8.96
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA (2001) 8.56
Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiology Study. Ann Epidemiol (1999) 8.33
Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med (1999) 7.99
Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev (2000) 7.81
The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care (2000) 7.41
Implementation of group sequential logrank tests in a maximum duration trial. Biometrics (1990) 6.32
Preventing non-insulin-dependent diabetes. Diabetes (1995) 6.16
Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol (2000) 5.81
Diabetes mellitus, coronary heart disease incidence, and death from all causes in African American and European American women: The NHANES I epidemiologic follow-up study. J Clin Epidemiol (2000) 5.49
Trends in the prevalence and incidence of self-reported diabetes mellitus -- United States, 1980-1994. MMWR Morb Mortal Wkly Rep (1997) 5.45
Changing habits to delay diabetes. N Engl J Med (2001) 5.30
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med (2006) 19.09
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med (2015) 18.66
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care (2007) 8.43
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75
Multidetector computed tomography for acute pulmonary embolism. N Engl J Med (2006) 7.57
A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med (2012) 7.51
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med (2011) 7.42
The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics (2006) 7.19
Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care (2006) 7.09
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med (2009) 6.89
Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med (2005) 6.63
The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol (2004) 6.53
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med (2005) 5.76
Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res (2004) 5.74
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab (2006) 5.33
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care (2005) 5.10
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes (2004) 4.44
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet (2012) 4.33
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab (2008) 4.29
Low serum testosterone and mortality in older men. J Clin Endocrinol Metab (2007) 4.27
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care (2003) 4.22
Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med (2010) 4.15
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09
Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care (2005) 4.08
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care (2002) 3.96
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol (2008) 3.83
A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care (2003) 3.57
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev (2004) 3.56
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care (2008) 3.45
Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care (2003) 3.37
Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care (2008) 3.33
The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes (2003) 3.23
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care (2010) 3.20
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med (2011) 3.20
Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc (2007) 3.15
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes (2012) 3.11
Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med (2002) 3.06
Predictors of acute complications in children with type 1 diabetes. JAMA (2002) 3.04
Tests of glycemia in diabetes. Diabetes Care (2004) 3.03
Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab (2006) 2.98
Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care (2012) 2.90
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care (2008) 2.87
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem (2011) 2.82
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes (2005) 2.80
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes (2003) 2.76
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care (2007) 2.71
Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program. Diabetes Care (2003) 2.69
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2002) 2.69
A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1. Diabetes Care (2007) 2.67
Testosterone and estradiol among older men. J Clin Endocrinol Metab (2005) 2.63
Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited. Diabetes (2008) 2.60
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes (2008) 2.60